Menu
Back to User profile » Dr Parag Majmudar
Papers published by Dr Parag Majmudar:
Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert
Matossian C, Stephens JD, Rhee MK, Smith SE, Majmudar PA, Gollamudi SR, Patel RH, Rosselson ME, Bauskar A, Montieth A, Silva FQ, Vantipalli S, Gibson A, Metzinger JL, Goldstein MH
Clinical Ophthalmology 2022, 16:2429-2440
Published Date: 6 August 2022
Pachymetric Assessment After EpiSmart® Epithelium-on Cross-Linking for Keratoconus and Post-Surgical Ectasia
Vaidya NS, Daneshmand A, Epstein RJ, Majmudar PA, Belin MW, Parsons EC, Rubinfeld RS
Clinical Ophthalmology 2022, 16:1829-1835
Published Date: 8 June 2022
Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
Nichols KK, Holland E, Toyos MM, Peace JH, Majmudar P, Raychaudhuri A, Hamdani M, Roy M, Shojaei A
Clinical Ophthalmology 2018, 12:913-914
Published Date: 17 May 2018
Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial
Nichols KK, Holland E, Toyos MM, Peace JH, Majmudar P, Raychaudhuri A, Hamdani M, Roy M, Shojaei A
Clinical Ophthalmology 2018, 12:263-270
Published Date: 31 January 2018
The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye
Trattler WB, Majmudar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg DF
Clinical Ophthalmology 2017, 11:1423-1430
Published Date: 7 August 2017
Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
Nielsen SA, McDonald MB, Majmudar PA
Clinical Ophthalmology 2013, 7:725-726
Published Date: 15 April 2013
Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
Nielsen SA, McDonald MB, Majmudar PA
Clinical Ophthalmology 2013, 7:149-156
Published Date: 17 January 2013